2014年度業績ー論文
- Yamamoto T, Hidaka Y, Inaba M, Ishimura E, Ooyama H, Kakuta H, Moriwaki Y, Higami K, Ohtawara A, Hosoya T, Nishikawa H, Taniguchi A, Ueda T, Yamauchi T, Fujimori S, Mineo I,Yamanaka H.
Effects of febuxostat on serum urate level in Japanese hyperuricemia patients, Modern Rheumatology, 1:5, 2015
- Oka Y, Tashiro H, Sirasaki R, Yamamoto T, Akiyama N, Kawasugi K, Shirafuji N,Fujimori S.
Hyperuricemia in hematologic malignancies is caused by an insufficient urinary excretion. Nucleosides Nucleotides Nucleic Acids, 33:434-438, 2014
- Yamada Y, Nomura N, Yamada K, Kimura R, Fukushi D, Wakamatsu N, Matsuda Y, Yamauchi T, Ueda T, Hasegawa H, Nakamura M, Ichida K, Kaneko K, Fujimori S.
Hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiencies : HPRT1 mutations in new Japanese families and PRPP concentration. Nucleosides Nucleotides Nucleic Acids, 33:218-222, 2014
- Kaneko K, Iwamoto H, Yasuda M, Inazawa K, Yamaoka N, Fukuuchi T, Tamura Y, Uchida S, Mawatari K, Nakagomi K, Yamada Y, Fujimori S.
Proteomic analysis to examine the role of matrix proteins in a gouty tophus from a patient with recurrent gout. Nucleosides Nucleotides Nucleic Acids, 33:199-207, 2014
- Hosoya T, Ohno I, Nomura S, Hisatome I, Uchida S, Fujimori S, Yamamoto T, Hara S.
Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout. Clin Exp Nephrol, 18( 6):218-222, 2014
- Ishikawa T, Takahashi S, Morita K, Okinaga H, Teramoto T.
Induction of AhR-Mediated Gene Transcription by Coffee. PLoS ONE, 9, 7, e102152, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
Metabolic Syndrome Executive Summary of the Japan Atherosclerosis Society(JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version , Journal of Atherosclerosis and Thrombosis, 21( 1):1-5, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
Familial Hypercholesterolemia Executive Summary of the Japan Atherosclerosis Society(JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version, Journal of Atherosclerosis and Thrombosis, 21( 1):6-10, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K,
Other Types of Primary Hyperlipoproteinemia(Hyperlipidemia) Executive Summary of the Japan Atherosclerosis Society(JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version, Journal of Atherosclerosis and Thrombosis, 21( 2):82-85, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
Coronary Artery Disease Executive Summary of the Japan Atherosclerosis Society(JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version, J Atheroscler Thromb, 21( 2):86-92, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M,Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
Diabetes Mellitus Executive Summary of the Japan Atherosclerosis Society(JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version, J Atheroscler Thromb, 21(2):93-98, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
Chronic Kidney Disease Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version , J Atheroscler Thromb, 21( 3):173-174, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
Cerebrovascular Diseases Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version, J Atheroscler Thromb, 21(3):175-179, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
The Elderly Executive Summary of the Japan Atherosclerosis Society( JAS) Guidelines for the 21 Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version, J Atheroscler Thromb, 21( 3):180-185, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
Women Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version, J Atheroscler Thromb, 21( 4):291-295, 2014
- Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K.
Diagnosis of Atherosclerosis Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version, J Atheroscler Thromb, 21( 4):296-298, 2014
- 藤森 新
よく使う日常治療薬の正しい使い方 尿酸降下薬の正しい使い方, レジデントノート, 16 (4): 747-750, 2014
- 藤森 新
私はこう治療する 症状のない高尿酸血症の治療, 診断と治療, 102,( 6)921-924, 2014
- 藤森 新
【最新肥満症学−基礎・臨床研究の最前線−】肥満に起因ないし関連する疾患 成立機序・病態・管理・治療 高尿酸血症・痛風, 日本臨床, 72, 増刊4, 605-608, 2014
- 江藤一弘
SGLT2阻害薬の特徴を考察する, 医学と薬学, 71( 11):2065-2074, 2014
- 真下大和、江藤一弘
【糖尿病治療薬update −適正な血糖管理を目指して−】糖尿病治療薬の薬効と適応基準 インクレチン関連薬 GLP-1受容体作動薬, 日本臨床, 73( 3):433-437, 2014
- 鈴木綾子、江藤一弘
【2 型糖尿病における膵β細胞機能不全のメカニズム】Glucolipotoxicity と膵β細胞不全, 内分泌・糖尿病・代謝内科, 38( 4):305-311, 2014
- 盛田幸司
内分泌疾患に関するコンサルテーションQ&A 画像検査 1) 副腎偶発腫, 内分泌・糖尿病・代謝内科 , 40( 3):162, しんしゅん, 2015
- 江戸直樹
内分泌疾患に関するコンサルテーションQ&A 自他覚症状・身体所見 4) 多尿, 内分泌・糖尿病・代謝内科 , 40( 3):211-216, 2015
- 髙橋 諭、寺本民生
最新のガイドラインを学ぶ「動脈硬化性疾患予防ガイドライン」 , たんじゅうさん, 13:2-30, 2014
- 髙橋 諭、寺本民生
新春特集=薬物療法の動向2015 脂質異常症, MEDICAMENT NEWS, 2182:7-8, 2015
- 髙橋 諭、石川敏夫
病態生理と症例から学ぶ輸液ガイド, Medical Practice 臨時増刊号, 32:213-217, 2015